Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea

Conditions: Primary Dysmenorrhea Interventions: Drug: Vitex agnus-castus BNO 1095 (20 mg); Drug: Placebo Sponsors: Bionorica SE; FGK Clinical Research GmbH Recruiting

https://clinicaltrials.gov/study/NCT06211049

Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

More News: Agnus Castus | Chaste Tree | Chasteberry | Research | Women